Novartis to present key immunology data at AAAAI and AAD 2025, highlighting advances in CSU and HS treatments
Novartis announced it will present data from 17 abstracts, including investigator-initiated trials, across its immunology portfolio at the 2025 American Academy of Allergy Asthma and Immunology (AAAAI) and World… read more.
